Skip to content

Cluster-randomized Controlled Trial of Mindfulness-Based Cognitive Therapy Effects on Anxiety and Stress

Cluster-randomized Controlled Trial Examining the Effectiveness of Mindfulness-Based Cognitive Therapy for Anxiety and Stress Reduction Within College Students

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06019299
Enrollment
289
Registered
2023-08-31
Start date
2023-03-21
Completion date
2023-04-26
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Stress

Keywords

Mindfulness-Based Cognitive Therapy

Brief summary

To understand the potential effectiveness of a 4 week Mindfulness-Based Cognitive Therapy intervention delivered using a smartphone application for reducing anxiety and stress within college students.

Detailed description

The objective of this project is to understand the potential effectiveness of a 4 week Mindfulness-Based Cognitive Therapy intervention delivered using a smartphone application for reducing anxiety and stress within college students. Although in-person mindfulness-based cognitive therapy approaches have been found effective for reducing anxiety and stress; given the pervasiveness of anxiety and stress in this population, there is a need to provide alternative and accessible interventions to improve students' mental health. One such approach may be by leveraging existing tools such Sanvello - a free mindfulness-based cognitive therapy smartphone application - which could more easily be deployed across a broader population. Accordingly, using a cluster-randomized controlled design, this intervention will assess the extent to which 4-weeks of using the Sanvello application was effective for reducing anxiety and stress within college students.

Interventions

Participants were instructed to practice mindfulness daily using their instructed approaches for a period of 4 weeks.

Sponsors

Michigan State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Cluster randomized allocation to Mindfulness-Based Cognitive Therapy intervention or positive control intervention.

Eligibility

Sex/Gender
ALL
Age
17 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* Enrolled in course

Exclusion criteria

* Complete inattendance in course during the pretest and study period. * Opted out of data being available for research use

Design outcomes

Primary

MeasureTime frameDescription
State-Trait Anxiety InventoryChange from baseline, 4 weeks.Trait scale of the Spielberger State-Trait Inventory as an index of trait anxiety. The possible trait scores range from 20 to 80, with higher scores indicating greater levels of anxiety.
Perceived Stress ScaleChange from baseline, 4 weeks.The Perceived Stress Scale-4 as an index of perceived chronic stress levels. The possible scores range from 0 to 16, with higher scores indicating higher perceived chronic stress levels.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMatthew B Pontifex, PhD

Michigan State University

Participant flow

Recruitment details

Potential participants were enrolled in a single predominately first year-level college course in health-sciences at Michigan State University.

Baseline characteristics

Characteristic
Age, Continuous19.4 Years
STANDARD_DEVIATION 1.6
Education13.4 Years
STANDARD_DEVIATION 0.8
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
282 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
12 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
20 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
White
116 Participants
Sex: Female, Male
Female
95 Participants
Sex: Female, Male
Male
55 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1390 / 150
other
Total, other adverse events
0 / 1390 / 150
serious
Total, serious adverse events
0 / 1390 / 150

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026